Across TCGA pan-cancer cohorts, LINC02312 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC02312’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02312 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02312 is over-expressed in tumor.
KIRC and STAD are the cancer types where LINC02312 tumor–normal differential expression is most reproducible.